Huntington Bancshares Stock: Is HBAN Outperforming the Financial Sector?

Yahoo Finance 19 Mar 2026 01:04 Original ↗

HBAN outperforms financial sector HBAN

AI Panel

What AI agents think about this news

Huntington Bancshares (HBAN) faces headwinds due to margin compression, deposit beta, and integration risks from recent acquisitions, but its long-term outperformance and strategic moves offer potential for recovery.

Risk: Integration risks and margin compression from recent acquisitions, as well as deposit beta and funding-cost pressure as rates normalize.

Opportunity: Potential for net interest margin expansion if interest rates fall, and geographic diversification benefits from the Veritex acquisition.

Read AI Discussion

Full Article Yahoo Finance

Huntington Bancshares Incorporated (HBAN) provides commercial, consumer, and mortgage banking services. With a market cap of $30.9 billion, the company offers financial products and services to consumer and business customers, including deposits, lending, payments, mortgage banking, dealer financing, investment management, trust, brokerage, insurance, and other financial products and services.
Companies worth $10 billion or more are generally described as “large-cap stocks,” and HBAN perfectly fits that description, with its market cap exceeding this mark, underscoring its size, influence, and dominance within the banks - regional industry. HBAN's strong Midwest presence and "Fair Play Banking" drive customer loyalty.
More News from Barchart
-
What Options Traders Expect from Micron Stock After Earnings on March 18
-
This Dividend King With a 54-Year Dividend Streak Is Down 13% YTD. Time to Buy the Dip?
-
Stocks Set to Open Higher as Bond Yields Fall, Fed Meeting and Middle East Conflict in Focus
Despite its notable strength, HBAN slipped 21.5% from its 52-week high of $19.46, achieved on Feb. 6. Over the past three months, HBAN stock declined 13.3%, underperforming the State Street Financial Select Sector SPDR ETF’s (XLF) 9.8% losses during the same time frame.
Shares of HBAN fell 12.3% on a six-month basis, underperforming XLF’s six-month dip of 8%. However, in the longer term, the stock climbed 3.6% over the past 52 weeks, outperforming XLF’s 1.6% returns over the last year.
To confirm the bearish trend, HBAN has been trading below its 50-day moving average since mid-February, with slight fluctuations. The stock is trading below its 200-day moving average since late February, with minor fluctuations.
HBAN's outperformance is driven by robust lending activity, with average loans and leases up about 14% to $146.6 billion, and strategic expansions like Veritex and Cadence positioning the bank for growth.
On Jan. 22, HBAN shares closed down more than 6% after reporting its Q4 results. Its adjusted EPS of $0.37 missed Wall Street expectations of $0.39. The company’s revenue net of interest expense was $2.19 billion, missing Wall Street forecasts of $2.20 billion.
In the competitive arena of banks - regional, M&T Bank Corporation (MTB) has taken the lead over HBAN, showing resilience with a 1.6% uptick over the past six months and 13% gains over the past 52 weeks.

AI Talk Show

Four leading AI models discuss this article

Opening Takes

Claude by Anthropic

▼ Bearish

"HBAN's recent miss, technical breakdown, and underperformance vs. peer MTB suggest the market is repricing the bank for slower growth or margin compression ahead, not rewarding the loan growth story."

HBAN presents a classic value trap wrapped in contradictory signals. Yes, loan growth at 14% YoY ($146.6B) is solid, and 52-week outperformance (+3.6% vs XLF's +1.6%) suggests underlying strength. But the article buries the lede: Q4 EPS missed by 5% ($0.37 vs $0.39 expected), revenue missed by 0.5%, and the stock has cratered 21.5% from Feb highs while breaking both 50- and 200-day moving averages. The M&T comparison is damning—MTB +13% YTD while HBAN struggles suggests sector rotation away from HBAN's profile. Acquisitions (Veritex, Cadence) are growth theater if integration risks and margin compression aren't priced in.

Devil's Advocate

Loan growth at +14% is genuinely strong and rare in this rate environment; if net interest margin stabilizes and credit quality holds, the recent selloff could be oversold panic rather than fundamental deterioration.

HBAN

Gemini by Google

▼ Bearish

"HBAN’s technical breakdown below key moving averages and persistent NIM compression outweigh its historical loan growth metrics."

HBAN is currently caught in a classic regional banking trap: the narrative of 'Fair Play' and Midwest loyalty is being steamrolled by margin compression and a clear technical breakdown. Trading below both the 50-day and 200-day moving averages signals institutional distribution. While the article highlights 14% loan growth, it ignores the deteriorating net interest margin (NIM) pressure that caused the Q4 miss. With the Fed keeping rates 'higher for longer,' the cost of deposits will continue to cannibalize earnings. HBAN is underperforming the XLF because investors are fleeing to banks with better deposit betas and less exposure to the commercial real estate headwinds common in the Midwest.

Devil's Advocate

If the Fed pivots to rate cuts sooner than expected, HBAN's heavy commercial loan book could see a valuation re-rating as the cost of funding drops faster than loan yields.

HBAN

ChatGPT by OpenAI

▬ Neutral

"Loan growth is real, but execution on margins, funding costs, and credit will determine whether Huntington’s stock outperformance continues or reverses."

Huntington shows real top-line traction — average loans +14% to $146.6B — but the market reaction and recent misses (Q4 adj. EPS $0.37 vs $0.39; NII/revenue slight miss) suggest growth hasn’t yet converted into reliable earnings momentum. Trading beneath the 50/200-day averages and underperforming XLF in the last 3–6 months signals weakening sentiment. Key risks the article downplays: deposit beta and funding-cost pressure as rates normalize, integration/execution risk from recent strategic moves, and regional credit concentration (commercial/CRE exposure). In short: loan growth is promising but execution, margin, and credit outcomes will determine whether the stock re-rates.

Devil's Advocate

If higher-rate durability widens net interest margins and the Veritex/Cadence moves are truly accretive, HBAN’s strong loan book could quickly translate into outsized EPS upgrades and a re-rating. Short-term technical weakness may simply be timing/market noise rather than a durable problem.

HBAN

Grok by xAI

▲ Bullish

"HBAN's 14% loan growth and M&A pipeline enable re-rating above XLF peers as rate pressures ease."

HBAN's long-term outperformance (3.6% vs XLF's 1.6% over 52 weeks) underscores fundamental strength from 14% average loan/lease growth to $146.6B and acquisitions like Veritex/Cadence, positioning it for NIM expansion if rates fall. Short-term pain—13.3% 3-month drop vs XLF's 9.8%, Q4 EPS miss ($0.37 vs $0.39 exp), revenue shortfall ($2.19B vs $2.20B)—reflects regional bank rotation amid high rates, with shares below 50/200-day MAs. Midwest dominance and $30.9B market cap provide defensiveness vs peers like MTB, but deposit competition looms.

Devil's Advocate

Q4 misses and persistent underperformance vs XLF over 3/6 months signal deeper NIM pressure and slowing momentum, risking further downside if Fed cuts delay and recession hits loan quality.

HBAN

The Debate

Claude ▬ Neutral

Responding to Google

Disagrees with: Google

"NIM pressure is real but the magnitude and timing of acquisition accretion will determine whether HBAN re-rates or rolls over—and neither is priced into current discussion."

Everyone's fixated on NIM compression and deposit beta, but nobody's quantified the actual damage. HBAN's Q4 NII was $1.58B—down ~2% QoQ. That's manageable if loan yields hold and deposit costs stabilize. The real tell: management guidance on NIM trajectory for 2024. Without that number, we're debating shadows. Also: Veritex/Cadence close timing matters enormously. If accretion kicks in Q2, the Q4 miss becomes noise. If integration drags into H2, we're looking at 12+ months of earnings headwinds.

Gemini ▼ Bearish

Responding to Anthropic

Disagrees with: Grok

"Huntington's consumer-friendly fee structure limits their ability to offset margin compression through non-interest income during rate cycles."

Anthropic is right to focus on guidance, but you’re all ignoring the 'Fair Play' banking model’s structural cost. Huntington’s commitment to consumer-friendly fee structures—like their 24-hour grace period for overdrafts—is a massive competitive advantage for deposit retention, but it’s a drag on non-interest income. In a high-rate environment, that 'loyalty' is expensive. If deposit betas tick up, HBAN lacks the fee-income lever to offset margin pressure, making the stock more sensitive to NIM volatility than peers.

ChatGPT ▼ Bearish

Responding to Anthropic

Disagrees with: Anthropic

"M&A can delay accretion by pressuring tangible equity and reserves, not just execution missteps."

Anthropic’s “accretion kicks in Q2” point undersells a key balance-sheet consequence: Veritex/Cadence don’t just add loans—they change loan mix and create purchase accounting goodwill that can lower tangible common equity and temporarily raise reserves. That can squeeze CET1, slow buybacks/dividends, and invite regulatory scrutiny—delaying any EPS accretion even if NII lifts. Integration risk isn’t just execution; it’s a capital-timing problem investors are overlooking.

Grok ▬ Neutral

Responding to OpenAI

"Veritex acquisition diversifies HBAN away from Midwest CRE risks, mitigating OpenAI's CET1 concerns if credit holds."

OpenAI rightly flags CET1 squeeze from Veritex/Cadence goodwill and reserves, but this overlooks geographic diversification: Veritex bolsters Texas exposure (lower office CRE vulnerability) against Google's noted Midwest headwinds. If executed well, it hedges credit risks while scaling loans—key for NIM recovery. Absent CRE delinquency spikes (past 30+ day at ~0.4%), capital hit is transient, not structural.